Trials / Completed
CompletedNCT07217106
A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure
A Retrospective Assessment of Accelerated Guideline-Directed Medical Therapy for Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 342 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to evaluate the efficacy and safety of a Guideline-Directed Medical Therapy (GDMT) clinic within a general cardiology practice relative to usual care. This study analyzed data from patients with heart failure (HF) who were referred to the GDMT clinic at Massachusetts General Hospital (MGH). For the comparator arm, patients in the GDMT clinic were matched to data of patients contained within in the MGH Research Patient Data Repository (RPDR).
Conditions
Timeline
- Start date
- 2024-03-03
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2025-10-15
- Last updated
- 2025-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07217106. Inclusion in this directory is not an endorsement.